Gabapentin-Mepha 600mg
Gabapentin-Mepha 600mg is a medicine authorised by Swissmedic under authorisation number 66088. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 14 July 2017 and the authorisation is valid without a time limit. ATC code N02BF01 places the medicine in the group Analgesics.
| Authorisation number | 66088 |
|---|---|
| Name | Gabapentin-Mepha 600mg |
| Full name | Gabapentin-Mepha 600mg, Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N02BF01 |
| First authorisation | 14 July 2017 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Gabapentin-Mepha 600mg, Filmtabletten | B | 14 July 2017 |
| 2 | Gabapentin-Mepha 800mg, Filmtabletten | B | 14 July 2017 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 50 | Tablette(n) | N02BF01 | 01.07.1. | B |
| 2 | 100 | Tablette(n) | N02BF01 | 01.07.1. | B |
| 3 | 50 | Tablette(n) | N02BF01 | 01.07.1. | B |
| 4 | 100 | Tablette(n) | N02BF01 | 01.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Gabapentin-Mepha 600mg authorised in Switzerland?
Yes. Gabapentin-Mepha 600mg is authorised by Swissmedic under authorisation number 66088, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Gabapentin-Mepha 600mg have?
Gabapentin-Mepha 600mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Gabapentin-Mepha 600mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.